/ /

  • linkedin
  • Increase Font
  • Sharebar

    Accommodating IOL: 2 years follow-up

    Study results say lens improved visual recovery with minimal visual disturbances

     

    Take Home 

    The Synchrony dual-optic accommodative intraocular lens (Abbott Medical Optics) seems to be clinically safe and effective after 2 years of follow-up. The visual function at intermediate and far improved rapidly postoperatively. Half of patients require a +1 D prescription for near vision.

     

     

    Monza, Italy—The Synchrony dual-optic accommodative intraocular lens (IOL) (Abbott Medical Optics [AMO]) seems to be clinically safe and effective after 2 years of follow-up, according to Matteo Piovella, MD.

    In the study, visual function improved rapidly with uncorrected visual acuity (UCVA) that was safe for driving within 1 month postoperatively, said Dr. Piovella, medical director of the Centro Microchirurgia Ambulatoriale, Monza, Italy. The computer distance vision was satisfactory within 1 week of implantation, however, half of patients require a +1 D prescription for near vision.

    The Synchrony IOL is a one-piece, dual-optic silicone IOL that has a three-dimensional lens designed to fill the capsular bag. The IOL is 5.5 mm high plus the anterior optic (+32 D) with a 6.0-mm variable negative posterior optic. The optics are connected by spring haptics, and the overall size of the IOL is size 9.5 mm x 9.8 mm.

    The implantation procedure includes inserting the preloaded injector tip to the edge of the capsulorhexis and releasing the first optic by pushing the leading optic against the posterior capsule. The second optic is then delivered into the capsular bag, Dr. Piovella said., MD.

    Dr. Piovella advised about the importance of the capsulorhexis.

    “It must be perfectly round, centered, symmetric, intact, free of notches, and about 5 mm in size,” he stated. Femtocataract laser is the perfect technology to match all the needs for accommodative IOL implantation, he added.

    New Call-to-action

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results